loader

World Tenders & Procurement Opportunities

Search
Advanced Search

539042-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [140 MG; CÁP/COMP]

World Biggest Tenders Source

This tender with title 539042-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [140 MG; CÁP/COMP] has been published on Bidding Source portal dated 21 Aug 2025 for the country of Portugal. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Portugal

539042-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [140 MG; CÁP/COMP]
Contract Award
539042
Portugal
21 Aug 2025
English
Antineoplastic and immunomodulating agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

538881-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - IMUNOGLOBULINA ANTILINFÓCITOS (COELHO) [25 MG; PÓ P/ CONC P/A SOL P/ PERF; FRS] Portugal 540899-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] Portugal 541563-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - LEUPRORRELINA [45 MG; PÓ E SOLV P/ SOL INJ; SERINGA] Portugal 526703-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BRIGATINIB [180 MG; CÁP/ COMP] Portugal 527961-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - LENVATINIB [4 MG; CÁP/ COMP] Portugal 528776-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BRIGATINIB [180 MG; CÁP/ COMP] Portugal 512090-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RUXOLITINIB [15 MG; CÁP/ COMP] Portugal 512452-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - GUSELCUMAB [100 MG/1 ML; SOL INJ; CANETA] Portugal 512951-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PEGINTERFERÃO BETA-1A [125 MCG; CANETA] Portugal 513058-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - GUSELCUMAB [100 MG/1 ML; SOL INJ; CANETA] Portugal
Antineoplastic and immunomodulating agents Tenders
Portugal Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans